About Technology Issues FAQ

Links

Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis

Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.